Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 120

Results For "CAS"

1563 News Found

Omicron sublineage BA.2 a Variant of Concern: WHO
News | February 23, 2022

Omicron sublineage BA.2 a Variant of Concern: WHO

As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern


GSK introduces Haleon to the world
News | February 23, 2022

GSK introduces Haleon to the world

Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum


Agilent posts Q1 FY2022 revenue at US$ 1.67 billion
News | February 23, 2022

Agilent posts Q1 FY2022 revenue at US$ 1.67 billion

Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.


Merck completes acquisition of biopharma CDMO Exelead
Biotech | February 23, 2022

Merck completes acquisition of biopharma CDMO Exelead

Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science


AIIA launches ‘Ayush Start-up Challenge’
Startup | February 22, 2022

AIIA launches ‘Ayush Start-up Challenge’

AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector


Solvay invests in Zurich-based 3D printing startup
Startup | February 22, 2022

Solvay invests in Zurich-based 3D printing startup

9T Labs provides a cost-competitive solution for manufacturing that will allow structural CFRP parts to replace metals at a much faster rate in demanding applications in many sectors such as aerospace, automotive and healthcare


CanSinoBIO's Convidecia approved as heterologous booster in China
News | February 21, 2022

CanSinoBIO's Convidecia approved as heterologous booster in China

Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants


Syncona completes sale of Gyroscope to Novartis
News | February 20, 2022

Syncona completes sale of Gyroscope to Novartis

The transaction generates upfront cash proceeds of $442 million for Syncona's holding in Gyroscope


WHO grants prequalification of Actemra/RoActemra for critical COVID-19 patients
Drug Approval | February 20, 2022

WHO grants prequalification of Actemra/RoActemra for critical COVID-19 patients

Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra


Hinduja Global Solutions bags contract from the UK Health Security Agency to provide critical services
News | February 20, 2022

Hinduja Global Solutions bags contract from the UK Health Security Agency to provide critical services

The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.